The State of Texas Attorney General Files Lawsuit Against Acetaminophen Makers Over Autism Spectrum Claims

Texas Attorney General Paxton is taking legal action against the producers of Tylenol, claiming the corporations hid potential risks that the pain reliever created to children's neurological development.

The lawsuit follows four weeks after Donald Trump promoted an unproven link between consuming Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "betrayed America by profiting off of discomfort and marketing drugs ignoring the potential hazards."

The manufacturer says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These corporations deceived for years, deliberately risking countless individuals to boost earnings," Paxton, from the Republican party, stated.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the health of American women and children."

On its official site, the company also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that shows a proven link between taking acetaminophen and autism."

Organizations acting on behalf of physicians and medical practitioners agree.

ACOG has said paracetamol - the primary component in Tylenol - is a restricted selection for expectant mothers to address pain and fever, which can present major wellness concerns if left untreated.

"In over twenty years of studies on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the use of paracetamol in any trimester of gestation results in brain development issues in children," the association stated.

The lawsuit references recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

Last month, Trump generated worry from medical authorities when he instructed pregnant women to "fight like hell" not to consume acetaminophen when sick.

Federal regulators then issued a notice that doctors should contemplate reducing the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism in children has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would determine the source of autism in a short period.

But authorities warned that identifying a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a complicated interplay of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that impacts how individuals perceive and engage with the world, and is recognized using physician assessments.

In his legal document, the attorney general - aligned with the former president who is running for US Senate - alleges the manufacturer and J&J "willfully ignored and attempted to silence the science" around paracetamol and autism.

The case aims to force the corporations "eliminate any commercial messaging" that claims acetaminophen is reliable for pregnant women.

This legal action echoes the concerns of a group of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.

A federal judge dismissed the case, stating investigations from the parents' expert witnesses was inconclusive.